The rise in LC3-II was greater in microglial cells from the SOD1-G93A mouse model of amyotrophic lateral sclerosis (ALS) than the wild type, and peaked 15 min after agonist presentation (Fabbrizio et al., 2017). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.